Efficacy and safety of Abelmoschus moschatus capsules combined with tripterygium glycoside tablets on diabetic nephropathy: A systematic review and meta-analysis

被引:2
|
作者
Zhou, Peipei [1 ,2 ]
Hao, Zhenning [1 ,2 ]
Xu, Weilong [1 ,2 ]
Zhou, Xiqiao [1 ]
Yu, Jiangyi [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Affiliated Hosp, Dept Endocrinol, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Clin Med Coll 1, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetic nephropathy; Abelmoschus moschatus; Tripterygium glycosides; systematic review; meta-analysis; DISEASE; ALBUMINURIA; MANIHOT;
D O I
10.3389/fphar.2022.936678
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Diabetic nephropathy (DN) is one of the most serious chronic micro-vascular complications of diabetes and the leading cause of end-stage kidney disease (ESRD) worldwide, with reduced expectancy and quality of life and colossal financial and social burden worldwide. In spite of emerging treatments on DN, effective therapy on delaying the progression of DN is still lacking. In clinical practice, there are many studies focusing on Abelmoschus moschatus (AM) capsules together with Tripterygium glycoside (TG) tablets in the treatment of DN, and excellent results have been obtained. Objective: The study aimed to evaluate the efficacy and safety of AM combined with TG in the treatment of DN. Methods: Databases including PubMed, Web of Science, Cochrane Library, Embase, CNKI, WF, and VIP were searched from their inception to 1 March 2022. The "risk of bias " evaluation tool produced by the Cochrane Collaboration Handbook was used for evaluating the quality of the included studies. Revman 5.3 software was used for meta-analysis. Results: Here, 11 studies with a total of 1,072 participants were included for this meta-analysis. Our results showed that AM combined with TG plus basic treatment could lower levels of 24 h-UP [MD = -0.18; 95% CI: (-0.21, -0.14); p < 0.00001], Scr [MD = -15.29; 95% CI: (-28.69, -1.88); p = 0.03], and BUN [MD = -1.18; 95% CI: (-1.69, -0.68); p < 0.00001]. Meanwhile, the adverse reaction rate increased in the combination group [RR = 1.88; 95% CI (1.26, 2.82); p = 0.002]. Conclusion: Current evidence suggests that AM combined with TG may be more effective in the treatment of DN, which will be highly beneficial to further theoretical discussion and practical clinical applications. However, the safety cannot be ignored because of nearly increasing 2-fold adverse events, although they can be mitigated through systematic treatment. Meanwhile, due to low quality of the included studies, great possibility of publication bias, and large heterogeneity among different studies, the results of our review should be evaluated with more prudence and high-quality RCTs are warranted to confirm this in the future.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials
    Hua-Bin Guo
    Jia-Qing Peng
    Ke-Kai Xuan Wang
    Guang-Zhi Zhang
    Wei-Hong Zhong
    Gui-Xin Chen
    BMC Nephrology, 22
  • [22] Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials
    Guo, Hua-Bin
    Peng, Jia-Qing
    Xuan Wang
    Zhang, Ke-Kai
    Zhong, Guang-Zhi
    Chen, Wei-Hong
    Shi, Gui-Xin
    BMC NEPHROLOGY, 2021, 22 (01)
  • [23] Efficacy and safety of astragalus injection combined with Western medicine in the treatment of early diabetic nephropathy A protocol for systematic review and meta-analysis
    Li, Guojing
    Ai, Bichen
    Zhang, Weihua
    Feng, Xingzhong
    Jiang, Min
    MEDICINE, 2021, 100 (12) : E25096
  • [24] Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis
    Jianwei Yi
    Zhihong He
    Shizhang Xu
    Si Feng
    International Urology and Nephrology, 2019, 51 : 1987 - 1998
  • [25] THE SAFETY AND EFFICACY OF GLUCOCORTICOIDS IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Bhasin, Arrti
    Parackal, Anna
    Kim, Kevin
    Molnar, Amber
    Walsh, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 420 - 420
  • [26] Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis
    Yi, Jianwei
    He, Zhihong
    Xu, Shizhang
    Feng, Si
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (11) : 1987 - 1998
  • [27] Efficacy and safety of Shumian capsules in treating insomnia A systematic review and meta-analysis
    Wang, Cuiying
    Yang, Yuying
    Ding, Xiao
    Li, Jiamin
    Zhou, Xue
    Teng, Jing
    Qi, Xianghua
    MEDICINE, 2021, 100 (50) : E28194
  • [28] Efficacy and safety ofGinkgo bilobafor patients with early diabetic nephropathy A protocol for systematic review and meta-analysis
    Wang, Hongyun
    Yuan, Meilin
    Zou, Xinrong
    MEDICINE, 2020, 99 (35) : E21959
  • [29] Combination therapy of tripterygium glycosides plus valsartan in diabetic nephropathy treatment: A systematic review and meta-analysis
    Wan-chun Ye
    Jian-zhong Ye
    Cheng Zheng
    Xiao-wei He
    Jia-jie Huang
    Ren Ye
    Chinese Herbal Medicines, 2019, (02) : 222 - 230
  • [30] Combination therapy of tripterygium glycosides plus valsartan in diabetic nephropathy treatment: A systematic review and meta-analysis
    Ye, Wan-chun
    Ye, Jian-zhong
    Zheng, Cheng
    He, Xiao-wei
    Huang, Jia-jie
    Ye, Ren
    CHINESE HERBAL MEDICINES, 2019, 11 (02) : 222 - 230